15670026

Source:http://linkedlifedata.com/resource/pubmed/id/15670026

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0021107, umls-concept:C0030190, umls-concept:C0032105, umls-concept:C0038257, umls-concept:C0439857, umls-concept:C0948480, umls-concept:C1514307
pubmed:issue	2
pubmed:dateCreated	2005-1-26
pubmed:abstractText	The plasmin activation system is involved in the development of restenosis after percutaneous coronary interventions (PCI). Conflicting data exist concerning the role of plasminogen activator inhibitor-1 (PAI-1) and its predictive value for restenosis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101170508
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/thienopyridine
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1538-7933
pubmed:author	pubmed-author:BinderB RBR, pubmed-author:ChristGG, pubmed-author:GlogarDD, pubmed-author:Gottsauner-WolfMM, pubmed-author:Huber-BeckmannRR, pubmed-author:HuberKK, pubmed-author:NikfardjamMM, pubmed-author:WojtaJJ
pubmed:issnType	Print
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	233-9
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15670026-Aged, pubmed-meshheading:15670026-Angioplasty, Balloon, Coronary, pubmed-meshheading:15670026-Aspirin, pubmed-meshheading:15670026-Combined Modality Therapy, pubmed-meshheading:15670026-Coronary Restenosis, pubmed-meshheading:15670026-Female, pubmed-meshheading:15670026-Fibrinolysis, pubmed-meshheading:15670026-Fibrinolytic Agents, pubmed-meshheading:15670026-Humans, pubmed-meshheading:15670026-Male, pubmed-meshheading:15670026-Middle Aged, pubmed-meshheading:15670026-Plasminogen Activator Inhibitor 1, pubmed-meshheading:15670026-Predictive Value of Tests, pubmed-meshheading:15670026-Pyridines, pubmed-meshheading:15670026-Retrospective Studies, pubmed-meshheading:15670026-Stents, pubmed-meshheading:15670026-Ticlopidine, pubmed-meshheading:15670026-Tissue Plasminogen Activator
pubmed:year	2005
pubmed:articleTitle	Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
pubmed:affiliation	Department of Cardiology, Medical University of Vienna, Währingergürtel 18-20, A-1090 Vienna, Austria. guenter.christ@meduniwien.ac.at
pubmed:publicationType	Journal Article